News
ORMP
3.790
+7.37%
0.260
Weekly Report: what happened at ORMP last week (0406-0410)?
Weekly Report · 19h ago
Weekly Report: what happened at ORMP last week (0330-0403)?
Weekly Report · 04/06 10:23
Oramed Completes Oratech Sale and Strategic Lifeward Financing
TipRanks · 04/01 00:08
Oramed completes Oratech sale to Lifeward for shares, warrants, revenue-sharing payments
Reuters · 03/31 20:22
Weekly Report: what happened at ORMP last week (0323-0327)?
Weekly Report · 03/30 10:23
Oramed FY2025 profit rises to $64.0 million; revenue climbs to $2.0 million
Reuters · 03/26 21:16
Oramed: Q4 Earnings Snapshot
Barchart · 03/26 16:50
Lifeward closes strategic partnership agreement with Oramed
TipRanks · 03/25 20:45
Lifeward Closes The Strategic Partnership Agreement With Oramed Pharmaceuticals
Benzinga · 03/25 20:17
Lifeward closes strategic partnership with Oramed; access to capital grows to $47 million
Reuters · 03/25 20:12
LIFEWARD SUCCESSFULLY CLOSES ON STRATEGIC PARTNERSHIP WITH ORAMED
Reuters · 03/25 20:10
12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga · 03/23 21:05
Weekly Report: what happened at ORMP last week (0316-0320)?
Weekly Report · 03/23 10:20
Weekly Report: what happened at ORMP last week (0309-0313)?
Weekly Report · 03/16 10:19
Lifeward receives shareholder approval to close on partnership with Oramed
TipRanks · 03/13 12:23
Lifeward to partner with Oramed in deal providing access to up to USD 47 million
Reuters · 03/13 12:05
Lifeward Shareholders Approve Issuance Of Ordinary Shares Over Previously Announced Collaboration Deal With Oramed Pharmaceuticals
Benzinga · 03/13 12:03
LIFEWARD RECEIVES SHAREHOLDER APPROVAL TO CLOSE ON STRATEGIC PARTNERSHIP WITH ORAMED—CREATING DIVERSIFIED BIOMEDICAL COMPANY
Reuters · 03/13 12:00
Top 10 healthcare stocks with highest dividend yield amid volatile markets
Seeking Alpha · 03/09 14:19
Weekly Report: what happened at ORMP last week (0302-0306)?
Weekly Report · 03/09 10:19
More
Webull provides a variety of real-time ORMP stock news. You can receive the latest news about Oramed Pharmaceuticals Inc through multiple platforms. This information may help you make smarter investment decisions.
About ORMP
Oramed Pharmaceuticals Inc. is a pharmaceutical company engaged in the research and development of pharmaceutical solutions with a technology platform. The Company has developed an oral dosage form intended to withstand the harsh environment of the stomach and effectively deliver active biological insulin or other proteins. Its Protein Oral Delivery (POD) technology is designed to protect drug integrity and increase absorption. Its pipeline includes ORMD-0801 (Oral Insulin) Diabetes, ORMD-0801 (Oral Insulin) NASH, and ORMD 0901 (Oral GLP-1). Its oral insulin (ORMD-0801) has the potential to create a new paradigm in the treatment of diabetes through oral delivery of insulin at an earlier stage of treatment. Its oral insulin capsule (ORMD-0801) has shown a reduction of liver fat content in early clinical trials. It is also developing an oral Glucagon-like peptide-1 (GLP-1) analog capsule (ORMD-0901), which is an incretin hormone that stimulates the secretion of insulin from the pancreas.